ABT Abbott Laboratories

  1. Stocks
  2. Healthcare
  3. NYSE: ABT

Price (delayed)

$109.45

Market cap

$191.64B

P/E Ratio

25.16

Dividend/share

$1.84

EPS

$4.35

Enterprise value

$201.06B

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott ...

Highlights
ABT's P/E is 64% below its 5-year quarterly average of 70.8 and 19% below its last 4 quarters average of 31.1
The EPS has grown by 36% YoY and by 10% from the previous quarter
ABT's quick ratio is down by 5% since the previous quarter but it is up by 4.3% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: https://www.abbott.com
Peers: JNJ PFE MDT TMO

Key stats

What are the main financial stats of ABT
Market
Shares outstanding
1.75B
Market cap
$191.64B
Enterprise value
$201.06B
Valuations
Price to earnings (P/E)
25.16
Price to book (P/B)
5.42
Price to sales (P/S)
4.33
EV/EBIT
21
EV/EBITDA
15.47
EV/Sales
4.52
Earnings
Revenue
$44.51B
EBIT
$9.57B
EBITDA
$13B
Free cash flow
$8.15B
Per share
EPS
$4.35
Free cash flow per share
$4.63
Book value per share
$20.2
Revenue per share
$25.26
TBVPS
$21.91
Balance sheet
Total assets
$74.01B
Total liabilities
$38.38B
Debt
$17.09B
Equity
$35.63B
Working capital
$10.78B
Liquidity
Debt to equity
0.48
Current ratio
1.85
Quick ratio
1.21
Net debt/EBITDA
0.72
Margins
EBITDA margin
29.2%
Gross margin
57%
Net margin
17.4%
Operating margin
20.7%
Efficiency
Return on assets
10.4%
Return on equity
22%
Return on invested capital
28.1%
Return on capital employed
15.6%
Return on sales
21.5%
Dividend
Dividend yield
1.68%
DPS
$1.84
Payout ratio
42.3%

ABT stock price

How has the Abbott Laboratories stock price performed over time
Intraday
3.05%
1 week
6.75%
1 month
-3.8%
1 year
-2.01%
YTD
-22.23%
QTD
-7.53%

Financial performance

How have Abbott Laboratories's revenue and profit performed over time
Revenue
$44.51B
Gross profit
$25.39B
Operating income
$9.23B
Net income
$7.73B
Gross margin
57%
Net margin
17.4%
The operating income has grown by 38% YoY and by 10% from the previous quarter
Abbott Laboratories's net income has increased by 35% YoY and by 9% QoQ
The gross profit has increased by 20% year-on-year and by 3.5% since the previous quarter
The revenue has grown by 19% YoY and by 3.3% from the previous quarter

Growth

What is Abbott Laboratories's growth rate over time

Valuation

What is Abbott Laboratories stock price valuation
P/E
25.16
P/B
5.42
P/S
4.33
EV/EBIT
21
EV/EBITDA
15.47
EV/Sales
4.52
ABT's P/E is 64% below its 5-year quarterly average of 70.8 and 19% below its last 4 quarters average of 31.1
The EPS has grown by 36% YoY and by 10% from the previous quarter
ABT's price to book (P/B) is 13% higher than its 5-year quarterly average of 4.8 but 13% lower than its last 4 quarters average of 6.2
ABT's equity is up by 5% year-on-year
The revenue has grown by 19% YoY and by 3.3% from the previous quarter
ABT's P/S is 15% below its last 4 quarters average of 5.1 and 6% below its 5-year quarterly average of 4.6

Efficiency

How efficient is Abbott Laboratories business performance
The ROIC has grown by 37% YoY and by 8% from the previous quarter
Abbott Laboratories's return on assets has increased by 28% YoY and by 8% QoQ
ABT's ROE is up by 24% YoY and by 8% from the previous quarter
The ROS has grown by 16% YoY and by 6% from the previous quarter

Dividends

What is ABT's dividend history
Dividend details
DPS
$1.84
Dividend yield
1.68%
Payout ratio
42.3%
Recent dividends

Financial health

How did Abbott Laboratories financials performed over time
The total assets is 93% more than the total liabilities
The current ratio has increased by 6% YoY
ABT's quick ratio is down by 5% since the previous quarter but it is up by 4.3% year-on-year
Abbott Laboratories's debt is 52% lower than its equity
Abbott Laboratories's debt to equity has decreased by 13% YoY and by 4% from the previous quarter
Abbott Laboratories's debt has decreased by 7% YoY and by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.